Journal article · 2026 · Open access
Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice
International journal of research and scientific innovation, 13(6), 6448–6462 · Published 18 July 2026 · DOI 10.51244/ijrsi.2026.1306000479
In brief
“Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice” is a 2026 journal article by Aparnaa Upadhyaya and Jacqueline Brown, published in International journal of research and scientific innovation. OpenAlex counts 0 citations as of 18 November 2026. It is open access: the full text is free to read at International journal of research and scientific innovation.
- Citations
- 0
- References
- 16
- Authors
- 2
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of type 2 diabetes mellitus and obesity, becoming among the most widely prescribed pharmacologic therapies worldwide. Medications such as semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide have demonstrated substantial benefits in glycemic control, weight reduction, and cardiovascular risk reduction. As the use of these agents continues to expand, healthcare providers are increasingly recognizing adverse effects that extend beyond the gastrointestinal and metabolic systems. Emerging evidence suggests that GLP-1 receptor agonists may influence oral health through alterations in salivary gland function, delayed gastric emptying, reflux-related complications, dehydration, and changes in nutritional status. Reports of xerostomia, halitosis, taste disturbances, enamel erosion, dentinal hypersensitivity, and increased caries susceptibility have generated growing interest within the dental community. Emerging literature has also explored the potential impact of GLP-1 therapy on periodontal health, peri-implant tissues, and oral inflammatory processes. This narrative review examines the pharmacologic basis of GLP-1 receptor agonists and discusses their potential oral manifestations and implications for dental practice. Particular emphasis is placed on xerostomia, dental erosion, caries risk, oral mucosal changes, periodontal considerations, and the emerging concept of “Ozempic mouth.” The review also highlights clinical recommendations for dental professionals managing patients receiving GLP-1 receptor agonist therapy and identifies areas requiring future investigation. As the use of these medications continues to increase, dental practitioners must recognize potential oral complications and implement preventive strategies to optimize patient outcomes.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Upadhyaya, A., & Brown, J. (2026). Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice. International journal of research and scientific innovation, 13(6), 6448–6462. https://doi.org/10.51244/ijrsi.2026.1306000479
MLA 9
Upadhyaya, Aparnaa, and Jacqueline Brown. “Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice.” International journal of research and scientific innovation, vol. 13, no. 6, 2026, pp. 6448–6462. https://doi.org/10.51244/ijrsi.2026.1306000479.
Chicago
Upadhyaya, Aparnaa and Jacqueline Brown. 2026. “Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice.” International journal of research and scientific innovation 13 (6): 6448–6462. https://doi.org/10.51244/ijrsi.2026.1306000479.
Harvard
Upadhyaya, A. and Brown, J. (2026) ‘Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice’, International journal of research and scientific innovation, 13(6), pp. 6448–6462. doi:10.51244/ijrsi.2026.1306000479.
IEEE
A. Upadhyaya and J. Brown, “Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice,” International journal of research and scientific innovation, vol. 13, no. 6, pp. 6448–6462, 2026, doi: 10.51244/ijrsi.2026.1306000479.
BibTeX
@article{upadhyaya2026oral,
title = {{Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice}},
author = {Upadhyaya, Aparnaa and Brown, Jacqueline},
journal = {International journal of research and scientific innovation},
year = {2026},
volume = {13},
number = {6},
pages = {6448--6462},
doi = {10.51244/ijrsi.2026.1306000479},
url = {https://doi.org/10.51244/ijrsi.2026.1306000479}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- GLP-1 receptor agonists
- oral manifestations
- xerostomia
- dental erosion
- caries risk
- periodontal health
- peri-implant tissues
- oral mucosal changes
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Upadhyaya, A., & Brown, J. (2026). Oral Manifestations of Glucagon-Like Peptide-1 Receptor Agonist Therapy: Implications for Dental Practice. International journal of research and scientific innovation, 13(6), 6448–6462. https://doi.org/10.51244/ijrsi.2026.1306000479
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at International journal of research and scientific innovation: sign in and open the PDF from this page.
Who wrote this paper?
Aparnaa Upadhyaya, Jacqueline Brown.
What is the DOI of this paper?
10.51244/ijrsi.2026.1306000479, permanently at https://doi.org/10.51244/ijrsi.2026.1306000479. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.